Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	472.49	500.24	87.38
Graham Fair Price	-40.14	1171.45	1957.09
PEG	-36.90	0.44	-0.70
Price/Book	-5.42	2.51	2.66
Price/Cash Flow	-78.09	-112.78	514.74
Prices/Earnings	178.34	-59.49	21.37
Price/Sales	21.34	4.17	3.44
Price/FCF	-78.09	-112.78	514.74
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.87	0.28	0.30
Operating Margin	85.00	-0.03	0.02
ROA	-65.32	< 0.005	< 0.005
ROE	0.03	-0.01	-66.02
ROIC	0.01	-0.01	14.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.03	105.37
Dividends QOQ	-0.33	1769.02	530607.86
EBIT QOQ	-0.79	-2.48	-212.82
EPS QOQ	-0.31	-1.35	-341.13
FCF QOQ	-0.89	-5.43	-510.73
Revenue QOQ	0.01	-0.20	1573.12
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	43.26	54.52	26.04
Days Sales Outstanding (DSO)	62.62	61.84	-1.25
Inventory Turnover	2.08	1.65	-20.66
Debt/Capitalization	0.55	0.56	1.27
Quick Ratio	0.60	0.53	-12.26
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2340.41	2403.17	2.68
Cash	220.85	279.07	26.36
Capex	-81.28	-74.83	7.94
Free Cash Flow	12.08	-53.54	343.26
Revenue	1808.54	1447.55	-19.96
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.92	0.83	-9.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	28.02	169.65	505.47
Naive Interpretation	Member

06 - Financial Health · Bad

Rating